Bicara Therapeutics

BCAX · NASDAQ

$18.35+$0.88 (+5.04%)TodayMarket closed ·
Prev close $17.47

Who owns BCAX

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 70.9% of BCAX’s shares.

  • RA Capital Management, LP11.0%
  • T. Rowe Price Investment Management, Inc.9.6%
  • Invus Public Equities Advisors, LLC8.5%
  • Biocon Ltd.8.4%
  • Next 6 largest institutions33.3%
  • All other shareholders29.1%
Top institutional holders of BCAX
HolderShares% of shares
RA Capital Management, LP7.26M11.04%
T. Rowe Price Investment Management, Inc.6.34M9.65%
Invus Public Equities Advisors, LLC5.60M8.53%
Biocon Ltd.5.52M8.41%
Vestal Point Capital, LP5.25M7.99%
Deep Track Capital LP4.10M6.24%
BlackRock Institutional Trust Company, N.A.3.19M4.86%
Janus Henderson Investors3.17M4.83%
Red Tree Management, LLC3.16M4.82%
TPG Capital, L.P.3.01M4.58%

Largest mutual fund holders

Top mutual fund holders of BCAX
HolderShares% of shares
T. Rowe Price Small Cap Stock Fund2.15M3.27%
Vanguard Total Stock Market Index Fund1.68M2.55%
State Street SPDR S&P Biotech ETF1.16M1.76%
T. Rowe Price Institutional Small-Cap Stock Fund1.16M1.76%
iShares Russell 2000 ETF1.14M1.74%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $4.26M (19 trades) of BCAX on the open market, with no buys.

Latest BCAX insider transactions
InsiderTypeSharesValue
Cohlhepp RyanOption exercise17.50K—
Cohlhepp RyanSale3.44K$80.66K
Cohlhepp RyanSale14.06K$320.05K
Cohlhepp RyanOption exercise17.50K$66.32K
Larson JenniferAward285.00K—
Hyep IvanOption exercise12.50K—
Hyep IvanSale12.50K$349.59K
Hyep IvanOption exercise12.50K$47.37K
Mazumdar ClaireOption exercise10.00K—
Mazumdar ClaireSale10.00K$279.75K

Short interest

Settled Sep 30, 2026

Shares short
10.69M
Days to cover
14.20
% of shares outstanding
16.28%
Average daily volume
753.21K
Change since last report
−4.5%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.